4, with a number of ongoing dissemination trials evaluating it as a standalone to enhance SBIRT (Screening, Brief Intervention, and Referral to Treatment) in primary care settings by providing the intervention on site rather than referring individuals to specialty care, as many do not follow through on referral. It is also being evaluated in a range of settings where access to evidence-based therapies has been limited, including rural drug courts, Native American and First National Health Centers, and office-based buprenorphine maintenance.
